$CRL 0.32 Weak
- Date
- Jul 8, 2026
- Mentions
- 1
- Unique authors
- 1
- Sector
- biotech
- Stance
- neutral
- On card
- no
Sentiment history
No sentiment history available for $CRL yet.
Sentiment
Notable posts
-
neutral 30 eng
Citi added four names to its Catalyst Call List. Intuitive Surgical $ISRG, Charles River Laboratories $CRL and GE HealthCare $GEHC were added to its 90-day upside catalyst watch. Haemonetics $HAE was added to its 90-day downside catalyst watch.
view on X → -
bullish 26 eng
Morgan Stanley Upgrades $CRL to Overweight from Equalweight, Raises PT to $220 from $185 Analyst comments: "With a strong uptick in biopharma funding beginning to transition into RFPs and bookings, we think CRL is well positioned to benefit given its leading preclinical capabilities. We also believe recent acquisitions and divestitures offer clear upside risk to Street numbers from 2027 onward and help to reduce areas of historical volatility through the P&L, such as building out a more reliable NHP, or non-human primates, supply network. While small, additional upside could present itself from WuXi’s recent inclusion on the U.S. DoD’s 1260H list as well as Inotiv’s Chapter 11 filing. On AI, though we acknowledge a potential reduction in discovery work for CRL, we believe the company could see a notable uptick in safety testing as pharma/biopharma pipelines become smarter with lower barriers for taking shots on goal. Our recent New Approach Methodologies deep dive provided us comfort in the size of potential headwinds facing the business, even under aggressive NAM penetration scenarios, with the profit pool remaining intact. Despite growth lagging clinical-stage peers today, we see a clearer path for acceleration here and believe that’s what investors will assign value to versus concerns of stagnation. Taking these factors into consideration, we’ve moved our 2027 EPS estimates up low-single digits and upgrade CRL to Overweight with a $220 PT, implying a 14x 2026E EV/EBITDA multiple, from 12x prior." Analyst: Kallum Titchmarsh
view on X → -
neutral 20 eng
Tenet Market Wake-Up Summary 📷📷 June.17.26 $SPX $AMZN $ASTS $INTC $OUST $SMR $HOOD $COIN $NFLX $AEHR $ORCL $MSFT $MNTS $IONQ $KTOS $LZB $JBL $KMX $CRL $MAC $HUN $ALGT $IQV $RMD $ZGN $LDOS $QURE $CLPT $MYSE $YQ $IMDX @ripster47 | @TENETTRADEGROUP | @TenetCharts https://t.co/UZqrXoliGx
view on X →
Signal history
| Date | Score | Signal | Mentions | Rank |
|---|---|---|---|---|
| 2026-06-17 | 0.54 | Developing | 2 | — |
| 2026-07-08 | 0.32 | Weak | 1 | — |